Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed patients of bilateral facial Kalaf Epidermal and mixed melasma
Exclusion criteria
Exclusion criteria: Pregnant or lactating women Patients with history or presence of any skin allergy or allergy to hydroquinone Patients with history or presence of any serious disease including immunological conditions like HIV current malignancies diabetes mellitus Hypertension etc Patients who had used within 15 days prior to baseline any topical and systemic treatment for scalp diseases Patient with history of chemical peels and facial laser treatment within 9 months and use of sun protector creams
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Change in Patient Global Assessment (PtGA) for melasma severity on 100mm VAS Change in Dermatology life quality index (DLQI)Timepoint: before and after treatment | — |
Primary
| Measure | Time frame |
|---|---|
| Change in modified Melasma Area and Severity Index (mMASI)Timepoint: baseline to end of treatment | — |
Countries
India
Contacts
Luqman Unani Medical College Hospital and Research Centre